Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...

Three Australian volunteers who have dedicated years of their lives to supporting Australian men and families impacted by ...

By Dr Wendy Winnall - PCFA Research TeamA recent prostate cancer study from Canada has received a lot of publicity. This study measured the risk of ...

A published case series reports unexpected cancer remissions linked with fenbendazole use, prompting renewed discussion on ...

Using cancer’s own survival tricks against it, scientists may have found a new way to stay one step ahead of the disease.

Fatigue assessment when treatment is started may be an early clinical marker of adverse event risk, the researchers suggested ...

Philip Duncombe was just 52 when he was diagnosed with prostate cancer but a medical trial gave him and wife Sue eight months ...

CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex diagnostics for faster, personalized care.

Zydus Lifesciences has partnered with US-based Myriad Genetics to launch diagnostic tests assessing cancer risk in India, aiming to expand access to precision diagnostics.

Monte Rosa Therapeutics surged Tuesday after the biotech said every patients in a prostate cancer study responded to its treatment.

What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If there's no accompanying ...

A local Secret Santa is giving $1 million to deserving people in eastern Idaho this holiday season. Every day, from now until ...